
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma
Hongpeng Duan, Qiuhui Jiang, Long Liu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 3839-3853
Closed Access | Times Cited: 4
Hongpeng Duan, Qiuhui Jiang, Long Liu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 3839-3853
Closed Access | Times Cited: 4
Showing 4 citing articles:
Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
Yin-Che Wang, Cheng‐Hsien Lin, Yu‐Chen Su, et al.
Hematology (2025) Vol. 30, Iss. 1
Open Access
Yin-Che Wang, Cheng‐Hsien Lin, Yu‐Chen Su, et al.
Hematology (2025) Vol. 30, Iss. 1
Open Access
Novel drug combinations for newly diagnosed multiple myeloma: how can we improve on current regimens?
Sofía I. Quezada-Ramírez, Luz Tarín‐Arzaga, Andrés Gómez‐De León, et al.
Expert Review of Hematology (2025)
Closed Access
Sofía I. Quezada-Ramírez, Luz Tarín‐Arzaga, Andrés Gómez‐De León, et al.
Expert Review of Hematology (2025)
Closed Access
Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS data
Sara Fernández-Luis, Alejandra Comins‐Boo, Fernando Pérez-Pla, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Closed Access | Times Cited: 2
Sara Fernández-Luis, Alejandra Comins‐Boo, Fernando Pérez-Pla, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Closed Access | Times Cited: 2
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy
Vanda Strafella, Immacolata Attolico, Paola Carluccio, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 4345-4347
Closed Access | Times Cited: 1
Vanda Strafella, Immacolata Attolico, Paola Carluccio, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 4345-4347
Closed Access | Times Cited: 1
EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
Pellegrino Musto, Nicola Sgherza
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024073-e2024073
Open Access
Pellegrino Musto, Nicola Sgherza
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024073-e2024073
Open Access